Please use this identifier to cite or link to this item: http://hdl.handle.net/2445/126840
Title: The incidence, clearance and persistence of non-cervical human papillomavirus infections: a systematic review of the literature
Author: Taylor, Sylvia
Bunge, Eveline
Bakker, Marina
Castellsagué, Xavier
Keywords: Vacuna del papil·lomavirus
Càncer de coll uterí
Papillomavirus vaccines
Cervix cancer
Issue Date: 14-Jun-2016
Publisher: BioMed Central
Abstract: Background: Human papillomavirus (HPV) vaccines were designed to prevent cervical cancer in women and their provision remains a major public health need. However, HPV is also a major cause of non-cervical anogenital and oropharyngeal cancers and the potential benefit of vaccination likely extends beyond cervical cancer. Methods: A systematic literature search of PubMed (1995-2014) identified publications assessing the incidence, persistence, and clearance of non-cervical anogenital/oral HPV infections. Comparability with cervical HPV was assessed by identifying articles assessing the same or similar populations. Results: Available data suggest high incidence rates of non-cervical HPV infection in men and women, with HPV-16 predominating in all sites. The incidence of high risk HPV per 100 person-years ranged from 11.4 to 72.9 for penile infections, 6.7-47.9 at other male genital sites, and 4.4-36.7 and 5.3-23.4 for anal infections in men and women, respectively. The incidence per 100 person-years of oral infection with any HPV type ranged from 5.7 to 6.7 in men and 6.8-39.6 in women. Within the limitations of the data, there was a general pattern of higher incidence and clearance of non-cervical genital HPV infections, compared to cervical infections. HIV status, circumcision, number of sex partners and partner HPV status significantly influenced high-risk HPV incidence/clearance at male anogenital sites. Few studies assessed risk factors for oral HPV. Conclusions: Parallels appear to exist between the epidemiology of cervical and non-cervical HPV infections in terms of incidence, HPV-type distribution, and risk factors for infection. Available data suggest that non-cervical genital HPV infections may occur more frequently, with higher clearance rates, than cervical infections. More extensive studies could provide useful information for estimating vaccine impact, the wider cost-benefit of HPV vaccination, and guiding vaccination policy.
Note: Reproducció del document publicat a: https://doi.org/10.1186/s12879-016-1633-9
It is part of: BMC Infectious Diseases, 2016, vol. 16, num. 293
URI: http://hdl.handle.net/2445/126840
Related resource: https://doi.org/10.1186/s12879-016-1633-9
Appears in Collections:Articles publicats en revistes (Institut d'lnvestigació Biomèdica de Bellvitge (IDIBELL))

Files in This Item:
File Description SizeFormat 
TaylorS.pdf1.01 MBAdobe PDFView/Open


This item is licensed under a Creative Commons License Creative Commons